Teva Launches First Generic Version of Perforomist in US

Teva Launches First Generic Version of Perforomist in US

297729

Teva Launches First Generic Version of Perforomist in US

Teva Pharmaceuticals has launched the first generic version of Perforomist (formoterol fumarate inhalation solution) for the treatment of chronic obstructive pulmonary disease (COPD) in the U.S. “Teva is pleased to provide patients with first-to-market access to a generic version of Perforomist,” Christine Baeder, senior vice president and chief operating officer of US Generics, for Teva USA, said in a press release. Perforomist is a long-acting beta-2 adrenergic agonist (LABA) used with a nebulizer to control…

You must be logged in to read/download the full post.